These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 10652246)
1. Physiologically based pharmacokinetic modeling of glycyrrhizic acid, a compound subject to presystemic metabolism and enterohepatic cycling. Ploeger BA; Meulenbelt J; DeJongh J Toxicol Appl Pharmacol; 2000 Feb; 162(3):177-88. PubMed ID: 10652246 [TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling. Ploeger B; Mensinga T; Sips A; Seinen W; Meulenbelt J; DeJongh J Drug Metab Rev; 2001 May; 33(2):125-47. PubMed ID: 11495500 [TBL] [Abstract][Full Text] [Related]
3. A population physiologically based pharmacokinetic/pharmacodynamic model for the inhibition of 11-beta-hydroxysteroid dehydrogenase activity by glycyrrhetic acid. Ploeger B; Mensinga T; Sips A; Deerenberg C; Meulenbelt J; DeJongh J Toxicol Appl Pharmacol; 2001 Jan; 170(1):46-55. PubMed ID: 11141355 [TBL] [Abstract][Full Text] [Related]
4. Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate. Cosmetic Ingredient Review Expert Panel Int J Toxicol; 2007; 26 Suppl 2():79-112. PubMed ID: 17613133 [TBL] [Abstract][Full Text] [Related]
5. A human physiologically-based model for glycyrrhzic acid, a compound subject to presystemic metabolism and enterohepatic cycling. Ploeger B; Mensinga T; Sips A; Meulenbelt J; DeJongh J Pharm Res; 2000 Dec; 17(12):1516-25. PubMed ID: 11303962 [TBL] [Abstract][Full Text] [Related]
6. Kinetic analysis of glycyrrhetic acid, an active metabolite of glycyrrhizin, in rats: role of enterohepatic circulation. Kawakami J; Yamamura Y; Santa T; Kotaki H; Uchino K; Sawada Y; Iga T J Pharm Sci; 1993 Mar; 82(3):301-5. PubMed ID: 8450426 [TBL] [Abstract][Full Text] [Related]
7. Biliary excretion and enterohepatic cycling of glycyrrhizin in rats. Ichikawa T; Ishida S; Sakiya Y; Sawada Y; Hanano M J Pharm Sci; 1986 Jul; 75(7):672-5. PubMed ID: 3761168 [TBL] [Abstract][Full Text] [Related]
8. Glycyrrhetic acid in human blood after ingestion of glycyrrhizic acid in licorice. Gunnarsdóttir S; Jóhannesson T Pharmacol Toxicol; 1997 Dec; 81(6):300-2. PubMed ID: 9444673 [No Abstract] [Full Text] [Related]
10. [Effect of phospholipid on absorption of diammonium glycyrrhizinate]. Zhou L; Yang J; Zhang XY; Liu XQ; Wang GJ Yao Xue Xue Bao; 2008 Jan; 43(1):71-5. PubMed ID: 18357736 [TBL] [Abstract][Full Text] [Related]
11. The disposition of diammonium glycyrrhizinate and glycyrrhetinic acid in the isolated perfused rat intestine and liver. Yang J; Zhou L; Wang J; Wang G; Davey AK Planta Med; 2008 Sep; 74(11):1351-6. PubMed ID: 18671195 [TBL] [Abstract][Full Text] [Related]
12. Effects of glucose, fructose and 5-hydroxymethyl-2-furaldehyde on the presystemic metabolism and absorption of glycyrrhizin in rabbits. Hou YC; Ching H; Chao PD; Tsai SY; Wen KC; Hsieh PH; Hsiu SL J Pharm Pharmacol; 2005 Feb; 57(2):247-51. PubMed ID: 15720790 [TBL] [Abstract][Full Text] [Related]
13. Physiologically-based pharmacokinetic modeling of genistein in rats, Part I: Model development. Schlosser PM; Borghoff SJ; Coldham NG; David JA; Ghosh SK Risk Anal; 2006 Apr; 26(2):483-500. PubMed ID: 16573635 [TBL] [Abstract][Full Text] [Related]
14. HPLC determination of glycyrrhizin and glycyrrhetic acid in biological fluids, after licorice extract administration to humans and rats. Raggi MA; Bugamelli F; Nobile L; Schiavone P; Cantelli-Forti G Boll Chim Farm; 1994 Dec; 133(11):704-8. PubMed ID: 7654308 [TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacokinetic behavior of glycyrrhetic acid after oral administration of glycyrrhizic acid and Gancao-Fuzi-Tang. Gao QT; Chen XH; Bi KS Biol Pharm Bull; 2004 Feb; 27(2):226-8. PubMed ID: 14758039 [TBL] [Abstract][Full Text] [Related]
16. Absorption and enterohepatic circulation of baicalin in rats. Xing J; Chen X; Zhong D Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266 [TBL] [Abstract][Full Text] [Related]
17. A new analysis method for disposition kinetics of enterohepatic circulation of diclofenac in rats. Fukuyama T; Yamaoka K; Ohata Y; Nakagawa T Drug Metab Dispos; 1994; 22(3):479-85. PubMed ID: 8070327 [TBL] [Abstract][Full Text] [Related]
18. Profound difference of metabolic pharmacokinetics between pure glycyrrhizin and glycyrrhizin in licorice decoction. Hou YC; Hsiu SL; Ching H; Lin YT; Tsai SY; Wen KC; Chao PD Life Sci; 2005 Jan; 76(10):1167-76. PubMed ID: 15620580 [TBL] [Abstract][Full Text] [Related]
19. Asymptotics and bioavailability in a 17-compartment pharmacokinetic model with enterohepatic circulation and remetabolization. Horkovics-Kovats S; Zlatos P Math Biosci; 2006 Sep; 203(1):19-36. PubMed ID: 16616213 [TBL] [Abstract][Full Text] [Related]
20. A reversible clearance model for the enterohepatic circulation of drug and conjugate metabolite pair. Semmes RL; Shen DD Drug Metab Dispos; 1990; 18(1):80-7. PubMed ID: 1970782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]